➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Medtronic
Harvard Business School
Merck
Baxter

Last Updated: September 30, 2020

DrugPatentWatch Database Preview

Patent: 7,393,658

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,393,658
Title:Prion protein binding materials and methods of use
Abstract: Prion protein binding materials and methods for using the binding materials to detect or remove a prion protein from a sample, such as a biological fluid or an environmental sample. The binding materials are capable of binding to one or more forms of prion protein including cellular prion protein (PrPc), infectious prion protein (PrPsc), recombinant prion protein (PrPr), and proteinase resistant prion protein (PrPres). Prions from various species, including humans and hamsters, are bound by the binding materials.
Inventor(s): Carbonell; Ruben G. (Raleigh, NC), Shen; Honglue (Raleigh, NC), Gurgel; Patrick V. (Raleigh, NC), Wiltshire-Lyerly; Viteros (Raleigh, NC), Hammond; David J. (Laytonsville, MD), Burton; Steven J. (Little Eversden, GB)
Assignee: Pathogen Removal and Diagnostic Technologies, Inc. (Wilmington, DE) North Carolina State University (Raleigh, NC)
Application Number:10/817,117
Patent Claims:see list of patent claims

Details for Patent 7,393,658

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Grifols Usa, Llc PLASBUMIN albumin (human) SOLUTION 101138 1 1994-09-26   Start Trial Pathogen Removal and Diagnostic Technologies, Inc. (Wilmington, DE) North Carolina State University (Raleigh, NC) 2023-04-04 search
Baxalta Us Inc. FLEXBUMIN albumin human INJECTION, SOLUTION 101452 1 2014-07-31   Start Trial Pathogen Removal and Diagnostic Technologies, Inc. (Wilmington, DE) North Carolina State University (Raleigh, NC) 2023-04-04 search
Csl Behring Ag ALBURX albumin (human) SOLUTION 102366 1 2009-01-06   Start Trial Pathogen Removal and Diagnostic Technologies, Inc. (Wilmington, DE) North Carolina State University (Raleigh, NC) 2023-04-04 search
Grifols Usa, Llc ALBUTEIN albumin (human) INJECTION, SOLUTION 102478 1 2019-12-15   Start Trial Pathogen Removal and Diagnostic Technologies, Inc. (Wilmington, DE) North Carolina State University (Raleigh, NC) 2023-04-04 search
Grifols Usa, Llc HUMAN ALBUMIN GRIFOLS albumin (human) SOLUTION 103352 1 2003-06-11   Start Trial Pathogen Removal and Diagnostic Technologies, Inc. (Wilmington, DE) North Carolina State University (Raleigh, NC) 2023-04-04 search
Csl Behring Llc ALBUMINAR-25 albumin (human) SOLUTION 103955 1 2009-01-06   Start Trial Pathogen Removal and Diagnostic Technologies, Inc. (Wilmington, DE) North Carolina State University (Raleigh, NC) 2023-04-04 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Moodys
Harvard Business School
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.